CSTL insider Tobin Juvenal: 10,640 PSUs vest, 4,294 shares sold at $19.36
Rhea-AI Filing Summary
Castle Biosciences insider activity: The reporting person, Tobin W. Juvenal (Chief Commercial Officer), reported acquisition and disposition of common stock on 08/08/2025. He acquired 10,640 shares through performance-based stock units (PSUs) at $0 and disposed of 4,294 shares at $19.36. The PSUs are described as representing one share each and constitute the remaining 50% of a grant from December 23, 2022, which vested on August 9, 2024.
After the reported transactions the form shows 84,527 shares directly beneficially owned and 2,230 shares held indirectly by the Tobin W. and Susan M. Juvenal Family Revocable Trust. The report was submitted on behalf of the reporting person by an attorney-in-fact.
Positive
- 10,640 PSUs acquired at $0, reflecting the conversion of performance-based awards into common shares
- PSUs explicitly described as one-for-one rights to common stock and tied to a December 23, 2022 grant that vested on August 9, 2024
- Indirect trust holdings disclosed (2,230 shares), improving transparency about attributable ownership
Negative
- 4,294 shares sold at $19.36, reducing direct shareholdings
- Beneficial ownership decreased to 84,527 shares directly after the reported disposal
Insights
TL;DR: Officer received 10,640 PSUs and sold 4,294 shares at $19.36, leaving 84,527 shares directly owned; routine compensation and sale.
The filing shows compensation-related equity (10,640 PSUs) converting to common shares at no cash outlay and a contemporaneous cash sale of 4,294 shares at $19.36. This combination—vesting-driven acquisition plus a partial disposition—is consistent with typical executive liquidity following award vesting. The net direct holding reported is 84,527 shares, with an additional 2,230 shares held indirectly via a family trust. Impact on shareholders is informational; the filing does not state transaction rationale or signal material change to corporate strategy.
TL;DR: Disclosure documents vesting and sale activity; PSUs described explicitly and trust holdings disclosed, meeting Section 16 reporting expectations.
The Form 4 documents time-based PSU conversion and an open-market disposition consistent with standard insider reporting. The form identifies the reporting persons officer role and discloses the family revocable trust as an indirect holder, clarifying potential attribution. From a governance perspective the filing provides the required transparency on executive compensation realization and related share moves; it does not allege issues of compliance or control deficiencies within the submitted information.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance-Based Stock Unit | 10,640 | $0.00 | -- |
| Exercise | Common Stock | 10,640 | $0.00 | -- |
| Tax Withholding | Common Stock | 4,294 | $19.36 | $83K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Held by Tobin W and Susan M Juvenal Family Revocable Trust of which the Reporting Person and his spouse are the trustees and the Reporting Person, his spouse and their children are the beneficiaries. Each Performance-Based Stock Unit ("PSU") represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the PSUs granted on December 23, 2022, which were all subject to time-based vesting and vested in full on the one-year anniversary of August 9, 2024.
